{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:46:57Z","timestamp":1791362817161,"version":"4.3.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autoimmune cytopenias (AIC) are rare complications of allogeneic hematopoietic stem cell transplantation (HSCT). Autoimmune neutropenia (AIN) is the least common type of AIC, and data on its incidence, risk factors and prognosis are scarce. This study aims to describe the incidence of AIN, its potential risk factors, and its clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>This retrospective study included children who underwent a first allogeneic HSCT between 2015 and 2022. Patients with primary graft rejection were excluded. The primary endpoint was the incidence of AIN. Secondary endpoints included secondary graft failure (GF), overall survival (OS), and event-free survival (EFS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 208 patients were included, 30 of whom were diagnosed with AIN. The median time from HSCT to AIN diagnosis was 104 days, with a cumulative incidence of 8.73% (95%CI, 5.6-13.51) at 6 months and 14.74% (95%CI, 10.47-20.55) at 2 years after HSCT. No risk factors were found to be associated with AIN. The cumulative incidence of secondary GF at 2 years was 13.75% (95%CI, 5.38-32.68) in patients with AIN compared to 4.73% (95%CI, 2.39-9.25) in patients without AIN (p=0.06). There were no differences in terms of OS or EFS between patients with AIN and patients without AIN, with 3-year OS of 82.9% (95%CI, 63.6-92.5) vs 81.8% (95%CI, 75.26\u201386.77) (p=0.64) and 3-year EFS of 72.8% (95%CI, 52.8-85.4) vs 79% (95%CI, 72.2-84.31) (p=0.67). We identified two patients with specific human neutrophil alloantigen antibodies (anti-HNA), one of whom had a secondary graft failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AIN may be a more frequent complication in post-HSCT pediatric patients than previously reported. Patients with AIN may be at a higher risk of secondary GF, but whether the risk of secondary GF is an important issue in patients with AIN needs to be explored in larger cohorts of patients. The study of specific anti-HNA in high-risk AIN patients should be considered.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1640546","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T04:10:35Z","timestamp":1753330235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune neutropenia: a rare complication of allogeneic hematopoietic stem cell transplantation?"],"prefix":"10.3389","volume":"16","author":[{"given":"Mar\u00eda Isabel","family":"Ben\u00edtez Carabante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Morell Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Ur\u00eda Oficialdegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Casanovas L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Panesso Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alonso Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edaz-de-Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02248-9","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT","volume":"59","author":"Passweg","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09070.x","article-title":"Management of autoimmune diseases after haematopoietic stem cell transplantation","volume":"157","author":"Holbro","year":"2012","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.005","article-title":"Immune-mediated complications after hematopoietic stem cell transplantation","volume":"22","author":"Li","year":"2016","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.11.014","article-title":"Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience","volume":"20","author":"Faraci","year":"2014","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5045\/br.2017.52.2.119","article-title":"Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children","volume":"52","author":"Hwang-Bo","year":"2017","journal-title":"Blood Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbmt.2017.12.782","article-title":"Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"24","author":"Kruizinga","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018026963","article-title":"Immune cytopenia post-cord transplant in Hurler syndrome is a forme fruste of graft rejection","volume":"3","author":"Deambrosis","year":"2019","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.03.029","article-title":"High incidence of autoimmune disease after hematopoietic stem cell transplantation for chronic granulomatous disease","volume":"24","author":"Yanir","year":"2018","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000439002","article-title":"New insights in the pathogenesis of autoimmune hemolytic anemia","volume":"42","author":"Barcellini","year":"2015","journal-title":"Transfus Med Hemother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30404-X","article-title":"Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions","volume":"8","author":"Baur","year":"2021","journal-title":"Lancet Haematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-04912-6","article-title":"Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment","volume":"182","author":"Spadea","year":"2023","journal-title":"Eur J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13866","article-title":"How I manage Evans Syndrome and AIHA cases in children","volume":"172","author":"Miano","year":"2016","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12243","article-title":"Neutropenia associated with antihuman neutrophil antibodies following allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Shingai","year":"2014","journal-title":"Transplant Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02779.x","article-title":"Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor","volume":"113","author":"Pocock","year":"2001","journal-title":"Br J Haematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02330.x","article-title":"Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test","volume":"49","author":"Nguyen","year":"2009","journal-title":"Transfusion"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01511.x","article-title":"Neutrophil antibody diagnostics and screening: review of the classical versus the emerging","volume":"101","author":"Fung","year":"2011","journal-title":"Vox Sang"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12227","article-title":"Detection of granulocyte-reactive antibodies: a comparison of different methods","volume":"108","author":"Heinzl","year":"2015","journal-title":"Vox Sang"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.04.007","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: A report on behalf of the American society for transplantation and cellular th","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B20","first-page":"99","article-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","volume-title":"Conditioning","author":"Nagler","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: A report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41409-024-02348-6","article-title":"The 50th annual meeting of the European society for blood and marrow transplantation: physicians \u2013 poster session (P001-P755)","volume":"59","author":"Oficialdegui","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.07.022","article-title":"Predictors for autoimmune cytopenias after allogeneic hematopoietic cell transplantation in children","volume":"26","author":"Szanto","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1658-3876(08)50042-2","article-title":"Why implement universal leukoreduction","volume":"1","author":"Bassuni","year":"2008","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17830","article-title":"Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation","volume":"64","author":"Alswied","year":"2024","journal-title":"Transfusion"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12514","article-title":"Human neutrophil antigens: Nature, clinical significance and detection","volume":"48","author":"Browne","year":"2021","journal-title":"Int J Immunogenet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41409-019-0680-4","article-title":"Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP\/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"55","author":"Miller","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2217\/1750743X.1.1.39","article-title":"Post-hematopoietic stem cell transplantion immune-mediated cytopenias","volume":"1","author":"Tsirigotis","year":"2009","journal-title":"Immunotherapy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.790455","article-title":"Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study","volume":"12","author":"Schiavo","year":"2022","journal-title":"Article"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07469.x","article-title":"Absence of ABH antigens on neutrophils","volume":"60","author":"Dunstan","year":"1985","journal-title":"Br J Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178250","article-title":"The cs a and cs b red cell antigens of the cost blood group collection correspond to the HNA-3a and HNA-3b neutrophil antigens: unexpected twins with implications for sickle cell anemia","volume":"142","author":"De Oliveira Rios","year":"2023","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_752_19","article-title":"Anti-thymocyte globulin in haematology: Recent developments","volume":"150","author":"Siddiqui","year":"2019","journal-title":"Indian J Med Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.01.015","article-title":"Characterizing immune-mediated cytopenias after allogeneic hematopoietic cell transplantation for pediatric nonmalignant disorders","volume":"27","author":"Galvin","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1640546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T04:10:36Z","timestamp":1753330236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1640546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2025.1640546"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1640546","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"article-number":"1640546"}}